Baxalta Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
4
- Portfolio
-
2
- Exits
-
2
Baxalta Ventures General Information
Description
Baxalta Ventures was a corporate venture arm of Baxalta. The firm used to invest in the therapeutic, diagnostic, medical device, hematology, immunology, inflammation, oncology and software sectors. It was based on Cambridge, Massachusetts.
Contact Information
Investor Status
Out of Business
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 650 East Kendall Street
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Baxalta Ventures Investments (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| OncoResponse | 23-Mar-2017 | Early Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 00000 000000 00.0 |
| 000000 | 29-Mar-2016 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
| Syntimmune | 22-Mar-2016 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | 00000 000000 00.0 |
| Opsona Therapeutics | 01-Mar-2014 | Later Stage VC | 00.000 | Drug Discovery | Bankruptcy: Liquidation |
Baxalta Ventures Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Opsona Therapeutics | 13-Jan-2019 | Bankruptcy: Liquidation | |
| 0000000000 | 02-Nov-2018 | 000000000000000000 | 00.00 |
Baxalta Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
